Trading Day Review: Immunocore Holdings plc ADR (IMCR) Loses Momentum, Closing at 28.26

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

The price of Immunocore Holdings plc ADR (NASDAQ: IMCR) closed at $28.26 in the last session, down -3.88% from day before closing price of $29.40. In other words, the price has decreased by -$3.88 from its previous closing price. On the day, 0.52 million shares were traded. IMCR stock price reached its highest trading level at $29.67 during the session, while it also had its lowest trading level at $27.86.

Ratios:

We take a closer look at IMCR’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.57 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 67.45. For the most recent quarter (mrq), Quick Ratio is recorded 3.76 and its Current Ratio is at 3.78. In the meantime, Its Debt-to-Equity ratio is 1.27 whereas as Long-Term Debt/Eq ratio is at 1.14.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on December 13, 2024, Downgraded its rating to Equal-Weight and sets its target price to $35 from $74 previously.

On November 11, 2024, Mizuho Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $72 to $38.

On October 24, 2024, UBS started tracking the stock assigning a Sell rating and target price of $24.UBS initiated its Sell rating on October 24, 2024, with a $24 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 01 ’24 when St Leger Tina Amber sold 4,375 shares for $64.06 per share. The transaction valued at 280,262 led to the insider holds 0 shares of the business.

Berman David M sold 36,509 shares of IMCR for $2,504,158 on Feb 28 ’24. The HEAD OF R&D now owns 0 shares after completing the transaction at $68.59 per share. On Feb 27 ’24, another insider, Berman David M, who serves as the HEAD OF R&D of the company, sold 54,938 shares for $70.86 each. As a result, the insider received 3,893,030 and left with 0 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMCR now has a Market Capitalization of 1413926912 and an Enterprise Value of 993707072. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.75 while its Price-to-Book (P/B) ratio in mrq is 3.76. Its current Enterprise Value per Revenue stands at 3.354 whereas that against EBITDA is -15.314.

Stock Price History:

Over the past 52 weeks, IMCR has reached a high of $76.98, while it has fallen to a 52-week low of $28.17. The 50-Day Moving Average of the stock is -12.05%, while the 200-Day Moving Average is calculated to be -32.63%.

Shares Statistics:

According to the various share statistics, IMCR traded on average about 267.66K shares per day over the past 3-months and 317120 shares per day over the past 10 days. A total of 50.03M shares are outstanding, with a floating share count of 48.66M. Insiders hold about 2.74% of the company’s shares, while institutions hold 87.82% stake in the company. Shares short for IMCR as of 1732838400 were 7187346 with a Short Ratio of 26.85, compared to 1730332800 on 7969448. Therefore, it implies a Short% of Shares Outstanding of 7187346 and a Short% of Float of 16.370001000000002.

Most Popular